Pankaj K. Singh

This study shows that adaptation to cystine limitation stress in PDAC promotes tumor growth via lipid metabolism reprogramming, and lomitapide can inhibit this process and enhance chemotherapy.

This study uses genome-scale metabolic modeling with patient transcriptomic data to identify metabolic vulnerabilities in PDAC and suggest potential therapeutic targets and drug combinations.